Education
About Us
Working with TipRanks
Follow Us
Utah Medical Products (UTMD)
:UTMD
UTMD Stock Chart & Stats
$55.67
-$0.06(-0.11%)
At close: 4:00 PM EST
$55.67
-$0.06(-0.11%)
Day’s Range― - ―
52-Week Range$51.26 - $65.56
Previous CloseN/A
Volume4.21K
Average Volume (3M)14.41K
Market Cap
$183.73M
Enterprise Value$117.92M
Total Cash (Recent Filing)$82.18M
Total Debt (Recent Filing)$256.00K
Price to Earnings (P/E)16.2
Beta0.47
Next Earnings
Feb 03, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.14%
Share Statistics
EPS (TTM)0.82
Shares Outstanding3,203,672
10 Day Avg. Volume20,679
30 Day Avg. Volume14,415
Financial Highlights & Ratios
PEG Ratio-1.16
Price to Book (P/B)1.83
Price to Sales (P/S)5.26
P/FCF Ratio14.75
Enterprise Value/Market Cap0.64
Enterprise Value/Revenue3.04
Enterprise Value/Gross Profit5.56
Enterprise Value/Ebitda6.67
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Utah Medical Products News
UTMD FAQ
What was Utah Medical Products’s price range in the past 12 months?
Utah Medical Products lowest stock price was $51.26 and its highest was $65.56 in the past 12 months.
What is Utah Medical Products’s market cap?
Utah Medical Products’s market cap is $183.73M.
When is Utah Medical Products’s upcoming earnings report date?
Utah Medical Products’s upcoming earnings report date is Feb 03, 2026 which is in 45 days.
How were Utah Medical Products’s earnings last quarter?
Utah Medical Products released its earnings results on Oct 23, 2025. The company reported $0.82 earnings per share for the quarter, beating the consensus estimate of N/A by $0.82.
Is Utah Medical Products overvalued?
According to Wall Street analysts Utah Medical Products’s price is currently Overvalued.
Does Utah Medical Products pay dividends?
Utah Medical Products pays a Quarterly dividend of $0.31 which represents an annual dividend yield of 2.14%. See more information on Utah Medical Products dividends here
What is Utah Medical Products’s EPS estimate?
Utah Medical Products’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Utah Medical Products have?
Utah Medical Products has 3,203,672 shares outstanding.
What happened to Utah Medical Products’s price movement after its last earnings report?
Utah Medical Products reported an EPS of $0.82 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.939%.
Which hedge fund is a major shareholder of Utah Medical Products?
Currently, no hedge funds are holding shares in UTMD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Utah Medical Products Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
UTMD Sentiment 70%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Increased
By 63.7K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-6.31%
12-Months-Change
Fundamentals
Return on Equity
9.59%
Trailing 12-Months
Asset Growth
-5.95%
Trailing 12-Months
Company Description
Utah Medical Products
Utah Medical Products, Inc. (UTMD) is a leading medical device company focused on developing and manufacturing high-quality medical products primarily for the healthcare sector. Founded in 1978 and headquartered in Midvale, Utah, the company specializes in the design of innovative, proprietary products that cater to the needs of hospitals and healthcare professionals. UTMD's product lines include disposable devices used in critical areas such as neonatal care, urology, and surgical procedures, emphasizing safety and efficacy.
Technical Analysis
InfuSystem Holdings
―
Predictive Oncology
―
REPRO-MED Systems
―
Sanara MedTech
―
Sharps Technology, Inc.
―
Ownership Overview
0.69% Insiders
18.31% Mutual Funds
25.42% Other Institutional Investors
45.24% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---